Payment and Delivery Information

MaxMed Systems is operated by THEDERMALFILLER S.R.L., an independent European commercial intermediary operating within a regulated professional B2B procurement framework.

The platform coordinates sourcing, supplier alignment, commercial structuring and transaction execution between licensed healthcare professionals and authorised European medical supply entities operating under applicable Union and national legislation.

MaxMed Systems does not:

– manufacture medical products;
– operate as pharmaceutical wholesaler or distributor;
– maintain retail infrastructure or consumer sales systems;
– perform warehousing, fulfilment or transport activities;
– physically dispatch goods;
– provide medical advice or therapeutic supervision.

All products are supplied exclusively through authorised manufacturers, marketing authorisation holders or licensed medical supply operators legally entitled to place such products on the European market.

No public commercial offer is made through this website.
Access remains restricted to licensed healthcare professionals and authorised professional entities operating within a documented B2B framework.

SECTION:
TRANSACTION FORMATION

All transactions are processed exclusively through written professional communication and formal proforma invoicing.

Submission of an enquiry, quotation request, payment instruction or proforma invoice does not constitute automatic commercial acceptance or binding contractual formation.

A transaction becomes operationally confirmed only after:

– written confirmation issued by MaxMed Systems;
– verified receipt of cleared full advance payment;
– supplier-side allocation approval within the regulated supply chain.

MaxMed Systems reserves the right to:

– validate professional eligibility;
– request supplementary verification documentation;
– decline or suspend transactions prior to confirmation;
– adjust indicative conditions where supplier allocation or regulatory circumstances require modification.

Automatic acknowledgements, preliminary discussions or payment transmission alone do not create contractual obligations.

All commercial conditions, including pricing structure, execution timeframe, logistics coordination and product scope, are confirmed exclusively in written form.

SECTION:
PRICING STRUCTURE

All pricing communicated through the platform is:

– confidential;
– professional-use only;
– non-public;
– subject to supplier confirmation and allocation availability.

Quoted pricing remains time-sensitive due to allocation dynamics, manufacturer policy adjustments and cross-border procurement conditions.

Failure to proceed within the indicated confirmation timeframe may result in:

– revised pricing;
– supplier reallocation;
– execution delay;
– withdrawal of the proposed transaction structure.

MaxMed Systems does not operate consumer-style promotional campaigns, speculative retail pricing systems or marketplace discount mechanisms.

SECTION:
PAYMENT TERMS

Payment is accepted exclusively via bank transfer (SEPA or international wire transfer).

No card payments, instalment systems, anonymous payment methods, cash-on-delivery services or consumer payment gateways are accepted.

Funds must:

– be transferred in full;
– match the confirmed proforma amount;
– include the correct payment reference;
– originate from the verified contractual counterparty where applicable.

Banking fees, intermediary charges and currency conversion costs remain the responsibility of the sender.

Operational execution commences only after verified receipt of cleared funds.

Transactions may be placed on compliance hold pending verification of payment origin, professional eligibility or regulatory consistency.

SECTION:
FULFILMENT AND DELIVERY STRUCTURE

MaxMed Systems does not perform physical fulfilment, warehousing, transport or direct delivery activities.

Fulfilment execution is coordinated through authorised European supply partners operating within regulated pharmaceutical or medical device distribution frameworks.

Responsibility for:

– storage conditions;
– cold-chain integrity;
– batch handling;
– transport execution;
– export clearance where applicable;
– final dispatch and release of goods;

remains exclusively with the authorised fulfilment entity responsible for physical execution.

MaxMed Systems coordinates commercial execution and documentation flow but does not assume operational control over third-party logistics infrastructure.

SECTION:
DELIVERY FRAMEWORK

Delivery timelines are indicative, operationally dependent and non-guaranteed.

Execution timing may vary depending on:

– supplier allocation schedules;
– manufacturer release timing;
– regulatory clearance procedures;
– cross-border compliance requirements;
– transport capacity;
– cold-chain routing availability;
– customs or national import procedures where applicable.

Indicative execution timeframe:
up to three (3) weeks from confirmed payment verification unless otherwise confirmed in writing.

Delays arising from circumstances beyond reasonable operational control do not constitute breach of obligation.

MaxMed Systems coordinates execution continuity but does not guarantee fixed delivery dates.

SECTION:
REGULATORY RESPONSIBILITY

Transactions are facilitated exclusively within selected European jurisdictions and associated regulated territories.

Country availability is confirmed individually during professional verification and transaction assessment.

Clients remain solely responsible for ensuring compliance with:

– local import requirements;
– national professional licensing rules;
– clinic-level authorisations;
– local healthcare advertising restrictions;
– applicable healthcare regulations within their jurisdiction.

MaxMed Systems does not assume responsibility for jurisdiction-specific regulatory incompatibilities outside the agreed procurement structure.

SECTION:
REFUND AND CANCELLATION POLICY

Refunds are granted exclusively where:

– procurement becomes objectively impossible prior to dispatch; or
– the authorised fulfilment entity confirms inability to execute the transaction within the confirmed operational structure.

Where applicable:

– refunds are issued exclusively to the originating bank account;
– refunds are processed within fourteen (14) calendar days from written cancellation confirmation;
– intermediary banking timelines may affect effective crediting speed.

No withdrawal right applies within strictly professional B2B transactions conducted between commercial or licensed professional entities.

Once supplier allocation, regulatory preparation or execution workflow initiation has occurred, cancellation may no longer be possible except in cases of verified supplier-side non-performance.

SECTION:
RETURNS AND PRODUCT CLAIMS

Returns are accepted exclusively in objectively verifiable situations such as:

– documented transport damage;
– objectively incorrect product release;
– confirmed execution error attributable to the authorised fulfilment entity.

Written notification must be submitted within fourteen (14) calendar days from delivery reception.

All claims remain subject to supplier-side verification and documented assessment.

Returns are not accepted for:

– purchaser ordering errors;
– delayed commercial decisions;
– market price fluctuations;
– local resale limitations;
– inability to utilise products following confirmed execution.

SECTION:
LIMITATION OF LIABILITY

To the maximum extent permitted under applicable law, MaxMed Systems shall not be liable for:

– supplier-side allocation interruptions;
– manufacturer release delays;
– regulatory processing delays;
– customs or logistics disruptions;
– force majeure events;
– indirect or consequential commercial losses arising from third-party operational infrastructure.

Nothing within this framework excludes liability where such exclusion is prohibited under applicable law.

SECTION:
COMMERCIAL POSITIONING

MaxMed Systems operates as an independent commercial coordination layer within regulated European medical supply chains.

The platform is structured around:

– procedural clarity;
– professional verification;
– documented sourcing;
– invoice-based execution;
– operational transparency;
– regulated B2B commercial discipline.

Direct engagement outside this structured procurement framework may affect allocation continuity, transaction support, pricing consistency and operational predictability.

Last updated:
May 2026